α2-Adrenergic agonists including xylazine and dexmedetomidine inhibit norepinephrine transporter function in SK-N-SH cells

Neuroscience Letters

Volumn 541, Issue , 2013, Pages 184-189

  Park, Jin Won ^a   Chung, Hyun Woo ^b   Lee, Eun Jeong ^a   Jung, Kyung Ho ^a   Paik, Jin Young ^a   Lee, Kyung Han ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Konkuk University School of Medicine   (South Korea)

Author keywords

2 adrenergic agonist; Dexmedetomide; Nisoxetine; Norepinephrine transporter

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; DEXMEDETOMIDINE; NISOXETINE; NORADRENALIN TRANSPORTER; XYLAZINE; YOHIMBINE;

ARTICLE; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BINDING SITE; DRUG UPTAKE; HUMAN; HUMAN CELL; IC 50; IMMUNOBLOTTING; IN VITRO STUDY; NEGATIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIOIMMUNOPRECIPITATION; SYMPATHETIC NERVE CELL; TRANSPORT KINETICS; WESTERN BLOTTING;

3-IODOBENZYLGUANIDINE; ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; CELL LINE, TUMOR; DEXMEDETOMIDINE; FLUOXETINE; HUMANS; IODINE RADIOISOTOPES; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; PROTEIN BINDING; RECEPTORS, ADRENERGIC, ALPHA-2; XYLAZINE;

EID: 84876420826     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.02.022     Document Type: Article

References (25)

1. Amara S.G., Kuhar M.J. Neurotransmitter transporters: recent progress. Annu. Rev. Neurosci. 1993, 16:73-93.
2. Babich J.W., Graham W., Fischman A.J. Effect of adrenergic receptor ligands on metaiodobenzylguanidine uptake and storage in neuroblastoma cells. Eur. J. Nucl. Med. 1997, 24:538-543.
3. Bhana N., Goa K.L., McClellan K.J. Dexmedetomidine. Drugs 2000, 59:263-268.
4. Boyd R.E. Alpha2-adrenergic receptor agonists as analgesics. Curr. Top. Med. Chem. 2001, 1:193-197.
5. Crassous P.A., Denis C., Paris H., Sénard J.M. Interest of alpha2-adrenergic agonists and antagonists in clinical practice: background, facts and perspectives. Curr. Top. Med. Chem. 2007, 7:187-194.
6. Gregoretti C., Moglia B., Pelosi P., Navalesi P. Clonidine in perioperative medicine and intensive care unit: more than an anti-hypertensive drug. Curr. Drug Targets 2009, 10:799-814.
7. Gul S., Hanci V., Bahadir B., Acikgoz S., Bektas S., Ankarali H., Kalayci M., Acikgoz B. The effectiveness of dexmedetomidine in experimental spinal cord injury compared to methylprednisolone in rats. J. Clin. Neurosci. 2010, 17:490-494.
8. Hara K., Yanagihara N., Minami K., Hirano H., Sata T., Shigematsu A., Izumi F. Dual effects of intravenous anesthetics on the function of norepinephrine transporters. Anesthesiology 2000, 93:1329-1335.
9. Hara K., Yanagihara N., Minami K. Ketamine interacts with the noradrenaline transporter at a site partly overlapping the desipramine binding site. Naunyn Schmiedebergs Arch. Pharmacol. 1998, 358:328-333.
10. Kamibayashi T., Maze M. Clinical uses of alpha2-adrenergic agonists. Anesthesiology 2000, 93:1345-1349.
11. Ko B.H., Paik J.Y., Jung K.H., Bae J.S., Lee E.J., Choe Y.S., Kim B.T., Lee K.H. Effects of anesthetic agents on cellular 123I-MIBG transport and in vivo 123I-MIBG biodistribution. Eur. J. Nucl. Med. Mol. Imaging 2008, 35:554-561.
12. Kolby L., Bernhardt P., Levin-Jakobsen A.M., Johanson V., Wangberg B., Ahlman H., Forssell-Aronsson E., Nilsson O. Uptake of meta-iodobenzylguanidine in neuroendocrine tumours is mediated by vesicular monoamine transporters. Br. J. Cancer 2003, 89:1383-1388.
13. Kyles A.E., Waterman A.E., Livingston A. The spinal antinociceptive activity of the alpha-2 adrenoceptor agonist xylazine in sheep. Br. J. Pharmacol. 1993, 108:907-913.
14. Mandela P., Ordway G.A. The norepinephrine transporter and its regulation. J. Neurochem. 2006, 97:310-333.
15. Nishimura M., Sato K., Okada T., Yoshiya I., Schloss P., Shimada S., Tohyama M. Ketamine inhibits monoamine transporters expressed in human embryonic kidney 293 cells. Anesthesiology 1998, 88:768-774.
16. Nishina K., Akamatsu H., Mikawa K., Shiga M., Maekawa N., Obara H., Niwa Y. The effects of clonidine and dexmedetomidine on human neutrophil functions. Anesth. Analg. 1999, 88:452-458.
17. Salt P.J., Barnes P.K., Beswick F.J. Inhibition of neuronal and extraneuronal uptake of noradrenaline by ketamine in the isolated perfused rat heart. Br. J. Anaesth. 1979, 51:835-838.
18. Sanders R.D., Sun P., Patel S., Li M., Maze M., Ma D. Dexmedetomidine provides cortical neuroprotection: impact on anaesthetic-induced neuroapoptosis in the rat developing brain. Acta Anaesthesiol. Scand. 2010, 54:710-716.
19. Sato K., Kimura T., Nishikawa T., Tobe Y., Masaki Y. Neuroprotective effects of a combination of dexmedetomidine and hypothermia after incomplete cerebral ischemia in rats. Acta Anaesthesiol. Scand. 2010, 54:377-382.
20. Schoeler M., Loetscher P.D., Rossaint R., Fahlenkamp A.V., Eberhardt G., Rex S., Weis J., Coburn M. Dexmedetomidine is neuroprotective in an in vitro model for traumatic brain injury. BMC Neurol. 2012, 12:20.
21. Taggart D., Dubois S., Matthay K.K. Radiolabeled metaiodobenzylguanidine for imaging and therapy of neuroblastoma. Q. J. Nucl. Med. Mol. Imaging 2008, 52:403-418.
22. Talke P.O., Caldwell J.E., Richardson C.A., Kirkegaard-Nielsen H., Stafford M. The effects of dexmedetomidine on neuromuscular blockade in human volunteers. Anesth. Analg. 1999, 88:633-639.
23. Torres G.E., Gainetdinov R.R., Caron M.G. Plasma membrane monoamine transporters: structure, regulation and function. Nat. Rev. Neurosci. 2003, 4:13-25.
24. Zhao Y., Sun L. Antidepressants modulate the in vitro inhibitory effects of propofol and ketamine on norepinephrine and serotonin transporter function. J. Clin. Neurosci. 2008, 15:1264-1269.
25. Zhou Z., Zhen J., Karpowich N.K., Goetz R.M., Law C.J., Reith M.E., Wang D.N. LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake. Science 2007, 317:1390-1393.